Protecting workers and the surrounding environment from exposure to hazardous compounds poses an increasing challenge to pharmaceutical manufacturers as new and more potent active pharmaceutical ingredients (APIs) enter the processing pipeline, such as cytotoxic drugs to treat cancer.
Separation and purification processes potentially expose workers to harmful, biologically active, contaminating particulates and cataylysts filtered from the APIs. To help remedy the problem, Pall is introducing the GBK Containment System which provides the pharmaceutical industry with an all-in-one contained glove bag/housing system for filter change-out.
Biosynth carbohydrates
Within the carbohydrate product range, Biosynth offers tools for glycobiology, chemo-enzymatic...
Cayman Chemical Stem Cell Small Molecule Screening Library
The screening library contains more than 140 small molecules that are known either to induce...
Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)
Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...
